期刊
MODERN RHEUMATOLOGY
卷 28, 期 4, 页码 712-715出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/14397595.2015.1134393
关键词
Biologics; Golimumab; Takayasu's arteritis
类别
资金
- Grants-in-Aid for Scientific Research [26461466] Funding Source: KAKEN
Recent studies suggested that anti-TNF- biological therapies are effective in treating Takayasu's arteritis (TA) refractory to conventional immunosuppressive therapy. However, the efficacy of golimumab (GLM) for TA therapy is unknown. We report four women with TA who were successfully treated with GLM. GLM was prescribed as induction therapy for three patients and as maintenance therapy for one patient. GLM showed therapeutic value and might be useful, together with other anti-TNF- agents, in treating TA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据